EnteroBiotix raised €22M in a funding round in May 2026. The company is based in Edinburgh, UK. Investors in the round: Scottish National Investment Bank, Thairm Bio. Data as of 20 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
